Combining TP53 mutation and isoform has the potential to improve clinical practice SR Das, B Delahunt, A Lasham, K Li, D Wright, C Print, T Slatter, ... Pathology, 2024 | | 2024 |
Dynamic ctDNA Mutational Complexity in Patients with Melanoma Receiving Immunotherapy S Fitzgerald, C Blenkiron, R Stephens, JA Mathy, T Somers-Edgar, ... Molecular Diagnosis & Therapy 27 (4), 537-550, 2023 | 1 | 2023 |
Close Links between Cold Shock Proteins and Cancer M Toulany, A Lasham Cancers 15 (9), 2421, 2023 | | 2023 |
Dynamic ctDNA mutational complexity in melanoma patients receiving immunotherapy S Fitzgerald, C Blenkiron, R Stephens, JA Mathy, T Somers-Edgar, ... medRxiv, 2022.09. 19.22280131, 2022 | | 2022 |
30,000 voices: Informing a better future for breast cancer in Aotearoa New Zealand N Knowlton, A Lasham, V Harvey, R Ramsaroop, S Kleinsman, A Gautier The University of Auckland, 2022 | 1 | 2022 |
30,000 voices: Informing a better future for breast cancer in Aotearoa New Zealand A Gautier, V Harvey, S Kleinsman, N Knowlton, A Lasham, R Ramsaroop Breast Cancer Foundation New Zealand, 2022 | 2 | 2022 |
30,000 Voices: Informing a Better Future for Breast Cancer in Aotearoa New Zealand: Te Rēhita Mate Ūtaetae-Breast Cancer Foundation National Register 2003-2020 A Gautier, V Harvey, S Kleinsman, N Knowlton, A Lasham, R Reena Breast Cancer Foundation NZ, 2022 | 3 | 2022 |
Breast Cancer Patient Prognosis Is Determined by the Interplay between TP53 Mutation and Alternative Transcript Expression: Insights from TP53 Long Amplicon … A Lasham, N Knowlton, SY Mehta, AW Braithwaite, CG Print Cancers 13 (7), 1531, 2021 | 11 | 2021 |
Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk RA Eiholzer, S Mehta, M Kazantseva, CJ Drummond, C McKinney, ... Cancers 12 (9), 2472, 2020 | 19 | 2020 |
N-methyl-D-aspartate receptor hypofunction in Meg-01 cells reveals a role for intracellular calcium homeostasis in balancing megakaryocytic-erythroid differentiation JI Hearn, TN Green, M Chopra, YNS Nursalim, L Ladvanszky, N Knowlton, ... Thrombosis and Haemostasis 120 (04), 671-686, 2020 | 12 | 2020 |
A predictor of early disease recurrence in patients with breast cancer using a cell-free RNA and protein liquid biopsy A Lasham, SJ Fitzgerald, N Knowlton, T Robb, P Tsai, MA Black, ... Clinical Breast Cancer 20 (2), 108-116, 2020 | 13 | 2020 |
Accessing a New Dimension in TP53 Biology: Multiplex Long Amplicon Digital PCR to Specifically Detect and Quantitate Individual TP53 Transcripts A Lasham, P Tsai, SJ Fitzgerald, SY Mehta, NS Knowlton, AW Braithwaite, ... Cancers 12 (3), 769, 2020 | 14 | 2020 |
Orthogonal assays for the identification of inhibitors of the single-stranded nucleic acid binding protein YB-1 AJ Trevarton, Y Zhou, D Yang, GW Rewcastle, JU Flanagan, ... Acta Pharmaceutica Sinica B 9 (5), 997-1007, 2019 | 9 | 2019 |
P2. 06-32 YB-1-A Key Factor in Mesothelioma Aggressive Growth and Behaviour K Schelch, T Johnson, K Sarun, A Burgess, A Lasham, G Reid Journal of Thoracic Oncology 13 (10), S755, 2018 | | 2018 |
P2. 06-16 YB-1: An Important Driver of Mesothelioma Drug Resistance and a Potential Novel Therapeutic Target T Johnson, K Schelch, K Sarun, M Williams, YY Cheng, A Lasham, G Reid Journal of Thoracic Oncology 13 (10), S748, 2018 | | 2018 |
Technical advances in plasma genomic biomarkers for mutation detection and monitoring in cancer patients S Fitzgerald, A Lasham, C Blenkiron, P Shields, B Lawrence, C Print Cancer Research 78 (13_Supplement), 3667-3667, 2018 | | 2018 |
Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes SY Mehta, BC Morten, J Antony, L Henderson, A Lasham, H Campbell, ... Oncotarget 9 (49), 29146, 2018 | 19 | 2018 |
Dysregulated expression of the MicroRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma TG Johnson, K Schelch, YY Cheng, M Williams, KH Sarun, MB Kirschner, ... Journal of Thoracic Oncology 13 (2), 258-272, 2018 | 44 | 2018 |
Regulation of the interferon-gamma (IFN-y) pathway by p63 and 133p53 isoform in different breast cancer subtypes A Braithwaite, H Campbell, R Reddel, J Anthony, KA Avery-Kiejda, ... Impact Journals LLC, 2018 | | 2018 |
Targeting YB-1 Induces Either Drug Sensitization or Resistance via Distinct Mechanisms in Malignant Pleural Mesothelioma T Johnson, K Schelch, K Sarun, A Lasham, N Van Zandwijk, G Reid JOURNAL OF THORACIC ONCOLOGY 12 (11), S2018-S2018, 2017 | | 2017 |